Top Stories Moderna’s mRNA Flu Vaccine Surpasses Standard in Phase III Trials Moderna is poised to seek regulatory approval for its mRNA flu vaccine following a successful Phase III trial. The vaccine, known as mRNA-1010, demonstrated... Editorial1 July, 2025